+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-05-21Number of Pages: 112

Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and Others) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022

Global Non-invasive Prenatal Testing Market: Snapshot

Non-invasive prenatal testing (NIPT) has been garnering higher adoption especially in the cases of high risk pregnant women. Chromosomal disorders such as Edwards syndrome, down syndrome, Turner syndrome, and Patau syndrome are some of the diseases that can be screened using non-invasive prenatal testing. Gynecologists and pregnant women prefer the safety, non-invasiveness, and accuracy of non-invasive prenatal testing technology, although there are other testing techniques available such as amniocentesis and chorionic villus sampling. In October 2011, the premier non-invasive prenatal testing technology was launched by Sequenom, Inc., a U.S.- based a leading provider of extremely sensitive laboratory tests and innovator in the domain of molecular technology. The company held the leading position in the market by volume as well as revenue.

In 2013, the global non-invasive prenatal testing market was pegged that US$0.5 bn. The global NIPT market is expected to obtain a revenue worth US$2.38 bn by 2022, advancing rapidly at a phenomenal CAGR of 17.50% between 2014 and 2022.

High Prevalence of Chromosomal Disorders in Europe to Amp up Growth

By geography, Latin America, the Middle East and Africa, North America, Asia Pacific, and Europe can be the key segments of the global market for non-invasive prenatal testing. Of these, North America accounted for a volume of 51.0% and revenue of 58.8% in the global market for non-invasive prenatal testing market in 2013. The U.S. has been responsible for the growth of the segment due to the presence of several significant market players in the region. The findings of Down Syndrome Education (DSE), the frequency of Down Syndrome in the U.S. has been rising at a fast pace, leading to 4,700 cases on an annual basis, reflected in almost one in about 830 births in the U.S.

The prevalence of the condition is even higher in the European countries. It was found that one in every 920 newborns was diagnosed with Down syndrome. Because traditional testing methods such as chorionic villus sampling and amniocentesis can lead to miscarriage, the non-invasive prenatal testing technology is being increasingly recognized as a safe technique. The advancement of non-invasive prenatal tests enables an assessment of cell-free DANA that float in maternal plasma, thereby posing no risk of miscarriage.

The non-invasive prenatal testing market in Asia Pacific has been prognosticated to gain a large revenue in the global market, representing a vast chunk of the total market. The trend of late pregnancy has been leading to a growing incidence of complications among expecting mothers. This has been one of the basic propellants of the non-invasive prenatal testing market in the region. China, Australia, India and Japan are likely to surface as major contributors to the market's growth.

MaterniT20 PLUS Held Largest Share in Global Non-invasive Prenatal Testing Market in 2013

The global market for non-invasive prenatal testing can be segmented by the type of tests too. VisibiliT, informaSeq, MaterniT20 PLUS, NIFTY, BambniTest, verifi, Harmony, PrenaTest, and Panorama are some of the key segments of the global market for non-invasive prenatal testing. During 2013 the MaterniT20 PLUS segment held a share of 36.1% of the overall market for NIPT. However, over the oncoming period, the NIFTY, Panorama, Bambni, and Verifi are slated to advance at a greater pace, waiting in the wings to replace the MaterniT20 PLUS market segment.

Berry Genomics, Illumina, Inc., BGI Health, Sequenom, Inc., LabCorp, Ariosa Diagnostics, LifeCodexx AG, and Natera, Inc. are some leading companies operating in the global market for non-invasive prenatal testing market. 

 

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Assumptions

      1.3.2 Sources

              1.3.2.1 Secondary Research

              1.3.2.2 Primary Research

      1.3.3 Models

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Non-Invasive Prenatal Testing (NIPT) Market (2013 & 2022)

2.2 Global Non-Invasive Prenatal Testing Market, by Test, 2013 (USD Million)

2.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2013 & 2022 (Value %)

2.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2013 & 2022 (Volume %)

 

Chapter 3 Global Non-Invasive Prenatal Testing Market Overview

3.1 Introduction

3.2 Major Chromosomal Aneuploidies and their Incidence Rate

      3.2.1 Down Syndrome

      3.2.2 Edwards Syndrome

      3.2.3 Patau Syndrome

      3.2.4 Turner Syndrome

      3.2.5 Klinefelter Syndrome

      3.2.6 Jacobs Syndrome

      3.2.7 Triple X Syndrome

3.3 Technological Approach for NIPT

3.4 Patent Landscape

      3.4.1 Major Patents issued to Sequenom, Inc.

      3.4.2 Major Patents issued to Ariosa Diagnostics, Inc.

      3.4.3 Major Patents issued to Natera, Inc.

      3.4.4 Major Patents issued to Verinata Health, Inc. (Illumina, Inc.)

      3.4.5 Major Patents issued to Cellscape Corporation

      3.4.6 Others

3.5 Market Drivers

      3.5.1 High incidence rate of babies born with Down syndrome

      3.5.2 Globally rising average maternal age

      3.5.3 Increasing demand for early and non-invasive fetal testing procedures

3.6 Market Restraints

      3.6.1 Regulatory guidelines and ethical hurdles

      3.6.2 Limitations of NIPT

      3.6.3 Availability of other screening and testing methods

3.7 Market Opportunities

      3.7.1 Capitalizing on the potential presented by the emerging markets of Asia

3.8 Porter’s Five Force Analysis: Global Non-Invasive Prenatal testing Market

      3.8.1 Bargaining power of suppliers

      3.8.2 Bargaining power of buyers

      3.8.3 Threat of substitutes

      3.8.4 Threat of new entrants

      3.8.5 Competitive rivalry

3.9 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography

      3.9.1 Market Attractive Analysis: Global Non-Invasive Prenatal Testing Market, by Geography

3.10 Competitive Landscape

      3.10.1 Market Share Analysis, by Key Players, 2013 (%)

      3.10.2 Non-Invasive Prenatal Testing: Market Share, by Key Players, 2013(%)

 

Chapter 4 Global Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Test

4.1 Overview

      4.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 – 2022 (USD Million)

      4.1.2 Global Non-Invasive Prenatal Testing Market Volume, by Test, 2012 – 2022 (Number of Tests Performed)

      4.1.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2013 & 2022 (Value %)

      4.1.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Test, 2013 & 2022 (Volume %)

4.2 BambniTest

      4.2.1 Global BambniTest Test Market Revenue, 2012 – 2022 (USD Million)

      4.2.2 Global BambniTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.3 Harmony Prenatal Test

      4.3.1 Global Harmony Test Market Revenue, 2012 – 2022 (USD Million)

      4.3.2 Global Harmony Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.4 informaSeq Prenatal Test

      4.4.1 Global informaSeq Test Market Revenue, 2014 – 2022 (USD Million)

      4.4.2 Global informaSeq Test Market Volume, 2014 – 2022 (Number of Tests Performed)

4.5 MaterniT21 PLUS

      4.5.1 Global MaterniT21 PLUS Test Market Revenue, 2012 – 2022 (USD Million)

      4.5.2 Global MaterniT21 PLUS Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.6 Non-invasive Fetal Trisomy (NIFTY) Test

      4.6.1 Global NIFTY Test Market Revenue, 2012 – 2022 (USD Million)

      4.6.2 Global NIFTY Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.7 Panorama Test

      4.7.1 Global Panorama Test Market Revenue, 2012 – 2022 (USD Million)

      4.7.2 Global Panorama Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.8 PrenaTest

      4.8.1 Global PrenaTest Test Market Revenue, 2012 – 2022 (USD Million)

      4.8.2 Global PrenaTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.9 verifi

      4.9.1 Global verifi Test Market Revenue, 2012 – 2022 (USD Million)

      4.9.2 Global verifi Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.10 VisibiliT Test

      4.10.1 Global VisibiliT Test Market Revenue, 2014 – 2022 (USD Million)

      4.10.2 Global VisibiliT Test Market Volume, 2014 – 2022 (Number of Tests Performed)

4.11 Others

      4.11.1 Global Other Tests Market Revenue, 2014 – 2022 (USD Million)

      4.11.2 Global Other Tests Market Volume, 2014 – 2022 (Number of Tests Performed)

 

Chapter 5 Global Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Geography

5.1 Overview

      5.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 – 2022 (USD Million)

      5.1.2 Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2012 – 2022 (Number of Tests Performed)

5.2 North America

      5.2.1 North America Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.2.2 North America Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

5.3 Europe

      5.3.1 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.3.2 Europe Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

5.4 Asia-Pacific

      5.4.1 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.4.2 Asia-Pacific Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

5.5 Rest of the World (RoW)

      5.5.1 RoW Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.5.2 RoW Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

 

Chapter 6 Recommendations

6.1 Focus on improving technology in order to increase the accuracy, reduce the duration of result generation and price

6.2 Focus on forming alliances with diagnostic service providers in Latin American and Asia-Pacific countries

6.3 Mergers and acquisitions

 

Chapter 7 Company Profiles

7.1 Ariosa Diagnostics, Inc.

      7.1.1 Company Overview

      7.1.2 Financial Overview

      7.1.3 Product Portfolio

      7.1.4 Business Strategies

      7.1.5 Recent Developments

7.2 Berry Genomics Co., Ltd.

      7.2.1 Company Overview

      7.2.2 Financial Overview

      7.2.3 Product Portfolio

      7.2.4 Business Strategies

      7.2.5 Recent Developments

7.3 BGI Diagnostics

      7.3.1 Company Overview

      7.3.2 Financial Overview

      7.3.3 Product Portfolio

      7.3.4 Business Strategies

      7.3.5 Recent Developments

7.4 Illumina, Inc.

      7.4.1 Company Overview

      7.4.2 Financial Overview

      7.4.3 Product Portfolio

      7.4.4 Business Strategies

      7.4.5 Recent Developments

7.5 Laboratory Corporation of America Holdings (LabCorp)

      7.5.1 Company Overview

      7.5.2 Financial Overview

      7.5.3 Product Portfolio

      7.5.4 Business Strategies

      7.5.5 Recent Developments

7.6 LifeCodexx AG

      7.6.1 Company Overview

      7.6.2 Financial Overview

      7.6.3 Product Portfolio

      7.6.4 Business Strategies

      7.6.5 Recent Developments

7.7 Natera, Inc.

      7.7.1 Company Overview

      7.7.2 Financial Overview

      7.7.3 Product Portfolio

      7.7.4 Business Strategies

      7.7.5 Recent Developments

7.8 Sequenom, Inc.

      7.8.1 Company Overview

      7.8.2 Financial Overview

      7.8.3 Product Portfolio

      7.8.4 Business Strategies

      7.8.5 Recent Developments

List of Figures

 

FIG. 1 Non-Invasive Prenatal Testing: Market Segmentation

FIG. 2 Global Non-Invasive Prenatal Testing Market, by Test, 2013 (USD Million)

FIG. 3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2013 & 2022 (Value %)

FIG. 4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2013 & 2022 (Volume %)

FIG. 5 Porter’s Five Force Analysis: Global Non-Invasive Prenatal Testing Market

FIG. 6 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography

FIG. 7 Non-Invasive Prenatal Testing: Market Share, by Key Players, 2013 (%)

FIG. 8 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2013 & 2022 (Value %)

FIG. 9 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Test, 2013 & 2022 (Volume %)

FIG. 10 Global BambniTest Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 11 Global BambniTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 12 Global Harmony Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 13 Global Harmony Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 14 Global informaSeq Test Market Revenue, 2014 – 2022 (USD Million)

FIG. 15 Global informaSeq Test Market Volume, 2014 – 2022 (Number of Tests Performed)

FIG. 16 Global MaterniT21 PLUS Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 17 Global MaterniT21 PLUS Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 18 Global NIFTY Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 19 Global NIFTY Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 20 Global Panorama Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 21 Global Panorama Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 22 Global PrenaTest Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 23 Global PrenaTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 24 Global verifi Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 25 Global verifi Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 26 Global VisibiliT Test Market Revenue, 2014 – 2022 (USD Million)

FIG. 27 Global VisibiliT Test Market Volume, 2014 – 2022 (Number of Tests Performed)

FIG. 28 Global Other Tests Market Revenue, 2014 – 2022 (USD Million)

FIG. 29 Global Other Tests Market Volume, 2014 – 2022 (Number of Tests Performed)

FIG. 30 North America Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022     (USD Million)

FIG. 31 North America Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 32 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 33 Europe Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 34 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 35 Asia-Pacific Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 36 RoW Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 37 RoW Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 38 LabCorp: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 39 Sequenom, Inc.: Annual Revenue, by Segment, 2011 – 2013 (USD Million)

List of Tables

 

TABLE 1 Market Snapshot: Global Non-Invasive Prenatal Testing (NIPT) Market (2013 & 2022)

TABLE 2 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 – 2022 (USD Million)

TABLE 3 Global Non-Invasive Prenatal Testing Market Volume, by Test, 2012 – 2022 (Number of Tests Performed)

TABLE 4 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 – 2022 (USD Million)

TABLE 5 Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2012 – 2022 (Number of Tests Performed)

TABLE 6 Ariosa Diagnostics, Inc.: Expenses & Revenue, 2011 – 2013 (USD Thousand)

TABLE 7 Sequenom, Inc.: Expenses & Revenue, 2011 – 2013 (USD Million)

 

Over the decade, the global non-invasive prenatal testing (NIPT) has shown a healthy growth. The rise in the global average of maternal age, coupled with the increasing incidence of Down syndrome in newborns, has boosted the market to a significant level. Additionally, the augmenting demand for timely and non-invasive fetal diagnosis is anticipated to propel the market in the coming years.

The global NIPT market is analyzed on the basis of the tests and the regional distribution of this market. Based on tests, the market is broadly classified into BambniTest, informaSeq, Harmony, MaterniT21 PLUS, Panorama, NIFTY, PrenaTest, VisibiliT, and verifi. Regionally, the worldwide market for NIPT is distributed among North America, Asia Pacific, Europe, and the Rest of the World.

The report present a comprehensive study of the global NIPT market with an analytical approach. Market drivers, restraints, opportunities, current and upcoming trends, and various segmentations of this market has been discussed at length in this study, making it a valuable source of guidance for market participants.

Overview of the Global NIPT Market

The global NIPT market stood at US$0.5 bn in 2013. Expanding at a CAGR of 17.50% over the period from 2014 to 2022, the market is projected to reach US$2.38 bn by the end of the forecast period.

According to the report, the first non-invasive prenatal test launched in the market was MaterniT21 PLUS. The test was introduced in 2011 and was intended to diagnose trisomy 21. In 2013, the market for MaterniT21 PLUS accounted for 36.1% of the total revenue generated in the NIPT market across the globe. However, this market segment is likely to lose ground on account of rising commercialization of panorama, Verifi, Bambni, and NIFTY during the forecast period. 

The NIPT market in North America emerged as the largest regional market of the global NIPT market in 2013 with a 58.8% share in terms of revenue and a 51% share in terms of volume. The presence of major market participants in the U.S. and a high level of awareness pertaining to NIPT in North America has boosted the regional market extensively.

The Asia Pacific NIPT market is showing immense potential for growth. Australia, Japan, India, and China are the key markets for NIPT in this region. A large population base of women choosing late pregnancy is expected to drive the Asia Pacific market for NIPT market over the forecast period.

The presence of untapped opportunities in developing economies across the globe provides a huge potential market for participants. However, the strict regulatory guidelines regarding non-invasive prenatal testing and the availability of alternative screening and testing procedures are likely inhibit the growth of the market to an extent.

Companies mentioned in the research report

Laboratory Corporation of America Holdings, Berry Genomics Co. Ltd., Illumina Inc., LifeCodexx AG, Sequenom Inc., BGI Diagnostics, Ariosa Diagnostics Inc., and Natera Inc. are the major companies functioning in the global NIPT market. Strategic partnership and alliance with hospitals, medical research centers, and clinical laboratories are the key trends among the market participants for the expansion of their business.

Key segments of the Global NIPT Market

By Test

  • BambniTest
  • Harmony
  • informaSeq
  • MaterniT21 PLUS
  • NIFTY
  • Panorama
  • PrenaTest
  • verifi
  • VisibiliT
  • Others

Major regions analyzed under this research report are: 

  • Europe
  • North America 
  • Asia Pacific 
  • Rest of the World 

This report gives you access to decisive data such as:

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments


 
 
Back To Top